-
Fair Pricing of Innovative Medicines From Definition to Application in CAR-T Cell Therapy
Sep 9, 2025, 16:22 PM -
Robotic Surgery: A Budget Analysis in the Italian Healthcare Setting
Sep 9, 2025, 16:22 PM -
Navigating Clinical Trial Design Under the EU Health Technology Assessment Regulation
Sep 9, 2025, 16:22 PM -
Implementing SISAQOL Recommendations: Insights From Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
Primary Expenditure Drivers and Future Challenges From Emerging Technologies in Brazilian Private Market Real-World Data Analysis From a Brazilian Employer-Sponsored, Self-Insured Health Plan
Sep 9, 2025, 16:22 PM -
Patient-Reported Outcomes After Total Knee Arthroplasty: Comparisons Across TKA Procedures and PRO Domains
Sep 9, 2025, 16:22 PM -
International Reference Pricing (IRP) Analysis for Original Medicines in Türkiye in 2024
Sep 9, 2025, 16:22 PM -
Towards Shaping Rare Diseases and Orphan Drugs Health Ecosystem in Saudi Arabia
Sep 9, 2025, 16:22 PM -
A Comparison of the NICE HST Program With Health Technology Assessments of Ultra-Orphan Drugs From France and Germany
Sep 9, 2025, 16:22 PM -
The Intercept of Real-World Evidence (RWE) Health Equity and Health Technology Assessment (HTA): A Structured Literature Review of Health Policy and Methodological Guidance
Sep 9, 2025, 16:22 PM -
Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Illness Among High-Risk Adults Aged 18-59 Years in Germany
Sep 9, 2025, 16:22 PM -
A Targeted Review of Caregiver Experiences of CAR-T Therapy in Ambulatory Settings
Sep 9, 2025, 16:22 PM -
Registry Participation in Rare Diseases: Insights from Stakeholders and an Adapted Targeted Literature Review (ATLR)
Sep 9, 2025, 16:22 PM -
Use of Multilevel Network Meta Regression (ML-NMR) Model in RET Mutation-Positive Medullary Thyroid Cancer (MTC)
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of Reimbursement Decisions for Targeted Therapies and Immunotherapies in NSCLC Across EU HTA Bodies
Sep 9, 2025, 16:22 PM -
Navigating Evidence Requirements for Joint Clinical Assessment (JCA): Practical Considerations for Systematic Literature Review (SLR) and Indirect Treatment Comparisons (ITCs)
Sep 9, 2025, 16:22 PM -
Satisfact-Home: Perception of Care Quality and Quality of Life in Patients With Solid Tumors Receiving Immune Checkpoint Inhibitors (ICIs) Therapy From Hospital To Home: A French Multicenter Prospective Observational Study
Sep 9, 2025, 16:22 PM -
Cross-Validation of the Glycated Hemoglobin HbA1c Translator: A Predictive Tool to Evaluate the Relationship Between Diabetes Complications and Associated Healthcare Costs
Sep 9, 2025, 16:22 PM -
Epidemiology and Outcomes in a Linked Cohort of Cancer Pathology and Electronic Medical Records From the PHARMO Data Network
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Lebrikizumab vs. Alternative Biologics in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis in the UK
Sep 9, 2025, 16:22 PM
